Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker NBP
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | Hillhouse Investment Management, Ltd. | 13.30M | 4.9% | SCHEDULE 13D/A ↗ |
| Nov 5, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | HHLR Advisors, Ltd. | 13.30M | 4.9% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | Wei Fu | 30.50M | 11.5% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | I-Bridge Capital GP, Ltd. | 9.22M | 3.5% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | I-Bridge Healthcare GP, L.P. | 9.22M | 3.5% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | I-Bridge Healthcare Fund, L.P. | 9.22M | 3.5% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge Capital GP, Ltd. | 23.37M | 8.8% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge Healthcare Fund GP II, L.P. | 14.15M | 5.3% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge Healthcare Fund II, L.P. | 14.15M | 5.3% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | Nova Aqua Limited | 7.13M | 2.7% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge II Investment Ten Limited | 2.37M | 0.9% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | CBC Spvii Limited | 5.57M | 2.1% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | IBC Investment Seven Limited | 3.64M | 1.4% | SCHEDULE 13D/A ↗ |
| Feb 3, 2026 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | CBC Investment I-Mab Limited | 11.78M | 4.4% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | Wei Fu | 27.49M | 10.4% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | I-Bridge Capital GP, Ltd. | 9.22M | 3.5% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | I-Bridge Healthcare GP, L.P. | 9.22M | 3.5% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | I-Bridge Healthcare Fund, L.P. | 9.22M | 3.5% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge Capital GP, Ltd. | 23.37M | 8.8% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge Healthcare Fund GP II, L.P. | 14.15M | 5.4% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge Healthcare Fund II, L.P. | 14.15M | 5.4% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | Nova Aqua Limited | 4.12M | 1.6% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | C-Bridge II Investment Ten Limited | 2.37M | 0.9% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | CBC Spvii Limited | 5.57M | 2.1% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | IBC Investment Seven Limited | 3.64M | 1.4% | SCHEDULE 13D/A ↗ |
| Aug 7, 2025 | SCHEDULE 13D/A (amended) | NBP NovaBridge Biosciences | CBC Investment I-Mab Limited | 11.78M | 4.5% | SCHEDULE 13D/A ↗ |
| Aug 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | Everest Medicines Limited | 42.52M | 16.1% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | Wei Fu | 33.57M | 17.9% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | I-Bridge Capital GP, Ltd. | 9.22M | 4.9% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | I-Bridge Healthcare GP, L.P. | 9.22M | 4.9% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | I-Bridge Healthcare Fund, L.P. | 9.22M | 4.9% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | C-Bridge Capital GP, Ltd. | 23.37M | 12.5% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | C-Bridge Healthcare Fund GP II, L.P. | 14.15M | 7.6% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | C-Bridge Healthcare Fund II, L.P. | 14.15M | 7.6% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | Nova Aqua Limited | 4.12M | 2.2% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | Everest Medicines Limited | 6.08M | 3.2% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | C-Bridge II Investment Ten Limited | 2.37M | 1.3% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | CBC Spvii Limited | 5.57M | 3.0% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | IBC Investment Seven Limited | 3.64M | 1.9% | SCHEDULE 13D ↗ |
| Feb 5, 2025 | SCHEDULE 13D | NBP NovaBridge Biosciences | CBC Investment I-Mab Limited | 11.78M | 6.3% | SCHEDULE 13D ↗ |
40 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 10:04 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances